Logotyp: till Uppsala universitets webbplats

uu.sePublikationer från Uppsala universitet
Ändra sökning
Länk till posten
Permanent länk

Direktlänk
Vesterberg, Olof
Publikationer (2 of 2) Visa alla publikationer
Roos, P. M., Vesterberg, O., Syversen, T., Flaten, T. P. & Nordberg, M. (2013). Metal Concentrations in Cerebrospinal Fluid and Blood Plasma from Patients with Amyotrophic Lateral Sclerosis. Biological Trace Element Research, 151(2), 159-170
Öppna denna publikation i ny flik eller fönster >>Metal Concentrations in Cerebrospinal Fluid and Blood Plasma from Patients with Amyotrophic Lateral Sclerosis
Visa övriga...
2013 (Engelska)Ingår i: Biological Trace Element Research, ISSN 0163-4984, E-ISSN 1559-0720, Vol. 151, nr 2, s. 159-170Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal degenerative disorder of motor neurons. The cause of this degeneration is unknown, and different causal hypotheses include genetic, viral, traumatic and environmental mechanisms. In this study, we have analyzed metal concentrations in cerebrospinal fluid (CSF) and blood plasma in a well-defined cohort (n = 17) of ALS patients diagnosed with quantitative electromyography. Metal analyses were performed with high-resolution inductively coupled plasma mass spectrometry. Statistically significant higher concentrations of manganese, aluminium, cadmium, cobalt, copper, zinc, lead, vanadium and uranium were found in ALS CSF compared to control CSF. We also report higher concentrations of these metals in ALS CSF than in ALS blood plasma, which indicate mechanisms of accumulation, e.g. inward directed transport. A pattern of multiple toxic metals is seen in ALS CSF. The results support the hypothesis that metals with neurotoxic effects are involved in the pathogenesis of ALS.

Nyckelord
ALS, Cerebrospinal fluid, HR-ICP-MS, Metals, Plasma, QEMG
Nationell ämneskategori
Naturvetenskap
Identifikatorer
urn:nbn:se:uu:diva-194733 (URN)10.1007/s12011-012-9547-x (DOI)000313735900001 ()
Tillgänglig från: 2013-02-19 Skapad: 2013-02-19 Senast uppdaterad: 2017-12-06Bibliografiskt granskad
Roos, P. M., Lierhagen, S., Flaten, T. P., Syversen, T., Vesterberg, O. & Nordberg, M. (2012). Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Experimental biology and medicine, 237(7), 803-810
Öppna denna publikation i ny flik eller fönster >>Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis
Visa övriga...
2012 (Engelska)Ingår i: Experimental biology and medicine, ISSN 1535-3702, E-ISSN 1535-3699, Vol. 237, nr 7, s. 803-810Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Neurotoxic properties of manganese (Mn) are well documented. It is less known that Mn contributes to the development of neurodegenerative disorders in the general population. This study presents Mn data from patients with amyotrophic lateral sclerosis (ALS) in a well-defined cohort diagnosed by electrophysiological methods. Cerebrospinal fluid (CSF) and plasma were collected from patients and controls. Mn concentrations were analyzed by high-resolution inductively coupled plasma mass spectrometry. Concentrations of Mn were significantly higher in ALS CSF (median 5.67 mu g/L) than in CSF from controls (median 2.08 mu g/L). Also, ALS CSF Mn concentrations were higher than ALS plasma Mn concentrations (median 0.91 mu g/L), suggesting transport of Mn into the central nervous system. The properties of barrier systems between blood and the brain are discussed and the possibility of Mn accumulation contributing to the relentless course of ALS is introduced.

Nyckelord
ALS, CSF, HR-ICP-MS, manganese, plasma
Nationell ämneskategori
Naturvetenskap
Identifikatorer
urn:nbn:se:uu:diva-183919 (URN)10.1258/ebm.2012.011396 (DOI)000308678800010 ()
Tillgänglig från: 2012-11-07 Skapad: 2012-11-05 Senast uppdaterad: 2023-08-03Bibliografiskt granskad
Organisationer

Sök vidare i DiVA

Visa alla publikationer